Comparison of Three Tranexamic Acid Dose Regimens in Patients Undergoing Cardiac Valve Surgery
Status:
Completed
Trial end date:
2021-06-15
Target enrollment:
Participant gender:
Summary
This study compares the effect of three different dose levels of tranexamic acid（TXA）in
reducing blood loss and transfusion requirements in cardiac valve surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital